← Evidence map

ArticleThe New England journal of medicine2017

Osimertinib in EGFR T790M-Positive Lung Cancer.

Tony S Mok et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

20 papers cite it

2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
this papertrialcites it

The trial

NCT04943406150 enrolled2020
Full record →Abstract, authors, funding and every citing paper · PMID 28514610